logo
Select company
Select metric
-7890.57%EBIT Margin
VS
Market
2
Sector
7
Industry
12
History
15
$ 1.3Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information

Ticker

ERNA

Company Name

ERNEXA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ERNEXA THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ERNA - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -38.51M-7890.57%$ 488K
3/31/2025$ -40.1M-7495.14%$ 535K
12/31/2024$ -37.76M-6487.46%$ 582K
9/30/2024$ -41.03M-6862.04%$ 598K
6/30/2024$ -21.73M-13412.35%$ 162K
3/31/2024$ -21.5M-18698.26%$ 115K
12/31/2023$ -21.06M-30966.18%$ 68K
9/30/2023$ -19.96M-39143.14%$ 51K
6/30/2023$ -21.68M0%$ 0
3/31/2023$ -20.57M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -59.14%.
  • Over the past 5 years, ERNEXA THERAPEUTICS INC's average EBIT % has been -10956.44%.
  • The median EBIT % for ERNEXA THERAPEUTICS INC during this period was -7495.14%
  • ERNEXA THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -59.14%.
  • The lowest EBIT % recorded by ERNEXA THERAPEUTICS INC in the same timeframe -39143.14%

ERNEXA THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
BRTX : BIORESTORATIVE THERAPIES INC -1771.91%VYNE : VYNE THERAPEUTICS INC -8096.85%IBIO : IBIO INC -4541.25%LEXX : LEXARIA BIOSCIENCE CORP -1849.39%LYRA : LYRA THERAPEUTICS INC -5041.17%PULM : PULMATRIX INC -2149.05%APRE : APREA THERAPEUTICS INC -1766.47%HCWB : HCW BIOLOGICS INC -6270.17%MGRX : MANGOCEUTICALS INC -2791.27%PHIO : PHIO PHARMACEUTICALS CORP -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for ERNEXA THERAPEUTICS INC is calculated as follows: EBIT [ $ -5.79M ] / Revenues [ $ 9.79M ]
(=) EBIT % [ -59.14% ]

ERNA - EBIT Margin, Last 5 years

-39143.14%

Minimum

Sep 30, 2023

-59.14%

Maximum

Sep 30, 2020

-10956.44%

Average

-7495.14%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%